Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

05/11/2021 08:00

Nov 5 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            240 mln             100 mln                    
                (+138.6 pct)         (-3.5 pct)                   
  Operating     loss 948 mln        loss 838 mln                  
  Recurring     loss 952 mln        loss 835 mln                  
  Net             loss 1.23         loss 756 mln                  
  EPS           loss 6.74 yen       loss 4.29 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T